sulfadiazine has been researched along with Tuberculosis, Drug-Resistant in 1 studies
Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bouzid, F | 1 |
| Astier, H | 1 |
| Osman, DA | 1 |
| Javelle, E | 1 |
| Hassan, MO | 1 |
| Simon, F | 1 |
| Garnotel, E | 1 |
| Drancourt, M | 1 |
1 other study available for sulfadiazine and Tuberculosis, Drug-Resistant
| Article | Year |
|---|---|
Extended spectrum of antibiotic susceptibility for tuberculosis, Djibouti.
Topics: Adult; Antitubercular Agents; Chloramphenicol; Clofazimine; Djibouti; Female; Humans; Male; Microbia | 2018 |